FAMILY HISTORY IN TURKISH ANKYLOSING SPONDYLITIS PATIENTS RECEIVING ANTI-TNF THERAPY

被引：0
|
作者：
Kalyoncu, U. [1 ]
Cetin, P. [2 ]
Karadag, O. [1 ]
Sari, I. [2 ]
Kilic, L. [1 ]
Ertenli, I. [1 ]
Akdogan, A. [1 ]
Kiraz, S. [1 ]
Birlik, M. [2 ]
Onen, F. [2 ]
Bilgen, S. A. [1 ]
Akkoc, N. [2 ]
机构：
[1] Hacettepe Univ, Fac Med, Dept Rheumatol, TR-06100 Ankara, Turkey
[2] Dokuz Eylul Univ, Fac Med, Dept Internal Med, Div Rheumatol, Izmir, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.5232
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0148
引用
收藏
页码：435 / 436
页数：2
相关论文
共 50 条
  • [41] Superior outcomes for military ankylosing spondylitis patients treated with anti-TNF
    Rees, Jonathan D.
    Bennett, A. N.
    Harris, D.
    Jones, T.
    JOURNAL OF THE ROYAL ARMY MEDICAL CORPS, 2014, 160 (04) : 310 - 313
  • [42] The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
    Murat Karkucak
    Erhan Capkin
    Ahmet Alver
    Ayse Akyuz
    Abdulkadir Kiris
    Emel Ak
    Murat Topbas
    Mehmet Tosun
    Clinical Rheumatology, 2010, 29 : 303 - 307
  • [43] Anti-TNFα therapy for ankylosing spondylitis -: What proportion of patients meet the current BSR guideline?
    Manhas, R.
    Young, L.
    McNally, J.
    Bradlow, A.
    RHEUMATOLOGY, 2006, 45 : I63 - I63
  • [44] INCIDENCE OF ACUTE ANTERIOR UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS DURING ANTI-TNF THERAPY IN SLOVAKIA
    Zlnay, M.
    Zlnay, D.
    Rovensky, J.
    Rybar, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1026 - 1026
  • [45] The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
    Karkucak, Murat
    Capkin, Erhan
    Alver, Ahmet
    Akyuz, Ayse
    Kiris, Abdulkadir
    Ak, Emel
    Topbas, Murat
    Tosun, Mehmet
    CLINICAL RHEUMATOLOGY, 2010, 29 (03) : 303 - 307
  • [46] DOES ANTI-TNF THERAPY CAUSE ANY CHANGE IN PLATELET ACTIVATION IN ANKYLOSING SPONDYLITIS PATIENTS?
    Pamuk, G. E.
    Pamuk, Oe N.
    Orum, H.
    Turgut, B.
    Demir, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 318 - 318
  • [47] Are there any predictors of response to anti-TNF therapy in patients with ankylosing spondylitis seen in clinical practice?
    Pradeep, John D.
    Gaffney, Karl
    Keat, Andrew
    Brooksby, Alan
    Macgregor, Alex
    Gibb, Alison
    Harris, Claire
    Leeder, Jane
    RHEUMATOLOGY, 2008, 47 : II75 - II75
  • [48] Does anti-tnf therapy cause any change in platelet activation in ankylosing spondylitis patients?
    Orum, Huseyin
    Pamuk, Gulsum Emel
    Pamuk, Omer Nuri
    Demir, Muzaffer
    Turgut, Burhan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 33 (02) : 154 - 159
  • [49] Fat Mass and Resistin: Predictive Factors For Anti-TNF Therapy Response In Ankylosing Spondylitis Patients
    Saad, Carla G. S.
    Abreu, Andressa Silva
    Medeiros Ribeiro, Ana Cristina
    Moraes, Julio C. B.
    Perandini, Luiz A.
    Dassouki, Thalita
    Pereira, Rosa M. R.
    Bonfa, Eloisa
    Pinto, Ana Lucia S.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1058 - S1058
  • [50] T cell count and TNFα secretion capacity in patients with ankylosing spondylitis (AS) after anti-TNF therapy.
    Brandt, J
    Maetzel, H
    Thiel, A
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S102 - S102
12345